Alpine Immune Sciences
Leah Zielinski has extensive experience in quality assurance and quality control within the biotechnology and biomedical sectors. Currently serving as Sr. Director of Quality at Alpine Immune Sciences, Inc. since February 2019, Leah previously held multiple leadership roles at Immune Design from May 2011 to December 2018, including Director of Quality and Assoc. Director of Quality. Prior experience includes a position as Sr. QA Associate at Seattle Biomedical Research Institute, focusing on the Malaria Vaccine Program, and various roles at Targeted Genetics from July 1996 to February 2009, culminating as Quality Control Manager. Leah holds a Bachelor of Science degree in Biology and Biochemistry from Gonzaga University, completed in 1996, and graduated from John F. Kennedy High School in 1992.
This person is not in any teams
This person is not in any offices
Alpine Immune Sciences
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- orbest-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.